2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Sjogren-Larsson Syndrome: new trials by email Literature Review of Sjogren-Larsson Syndrome trials Research Report on Sjogren-Larsson Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADX-629 Therapy for Sjogren-Larsson Syndrome ADX-629 - Sjogren-Larsson Syndrome | Phase 1 / Phase 2 | Completed | University of Nebraska | 8 | 2023-01-02 | 2026-05-05 |
| A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS) Active topical NS2 1% dermatologic cream, Vehicle placebo 0.0% NS2 dermatologic cream - Sjögren-Larsson Syndrome | Phase 2 | Completed | Aldeyra Therapeutics, Inc. | 12 | 2015-03-01 | 2022-12-13 |
Ichthyosis (2) · Cerebral Palsy (1) · Intellectual Disability (1) · Muscle Spasticity (1) · Retinal Diseases (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Infant, Newborn, Diseases (2) · Keratosis (2) · Lipid Metabolism Disorders (2) · Lipid Metabolism, Inborn Errors (2) · Lipidoses (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Nutritional and Metabolic Diseases (2) · Skin Abnormalities (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2)
ADX-629 (1)
Aldeyra Therapeutics, Inc. (1) · University of Nebraska (1)
United States (2)
William B Rizzo, MD (1) · William B. Rizzo, MD (1)